Featured Researchers

Dr. Robert Bristow and Dr. Paul Boutros



The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature. Led by Drs. Robert Bristow of the Princess Margaret Cancer Centre and Paul Boutros of the Ontario Institute for Cancer Research, CPC-GENE has uncovered the full set of mutations that can occur in the most common cancer in men. By fully cataloging these mutations, the CPC-GENE team was able to create a new signature that predicts at an early stage whether a prostate cancer tumour will become aggressive or not, allowing for personalized treatment.

Dr. Robert Bristow



Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer. Funded by Prostate Cancer Canada and led by Dr. Robert Bristow of the Princess Margaret Cancer Centre in Toronto, the findings were published in Nature Communications.

Dr. John Bell


 
Thanks to the dedication and enthusiasm of Mo Bros and Mo Sistas across the country, funds raised through Movember enable Prostate Cancer Canada to select and support research that will make a big difference in the lives of everyone affected by the most common cancer in men. A recent example of this us research being undertaken by Dr. John Bell of the University of Ottawa in the area of immunotherapy. More specifically, he and a team of researchers from a number of institutions across the country are engineering cancer-killing viruses. It is your moustaches and MOVEs that continue to make life-changing work possible. Please check out the video to learn more about the difference you're making!

Dr. Paul Boutros

 

To mark Prostate Cancer Awareness Month, we wanted to highlight some of the great research taking place that has been made possible through the generosity of Canadians like the work being led by Dr. Paul Boutros. Together, we are making a difference in the lives of the 1 in 7 Canadian men who will be diagnosed with prostate cancer and their families.

For more information and support:

 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive